These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 6304514)
41. Identification of Regulatory Mutations in SERPINC1 Affecting Vitamin D Response Elements Associated with Antithrombin Deficiency. Toderici M; de la Morena-Barrio ME; Padilla J; Miñano A; Antón AI; Iniesta JA; Herranz MT; Fernández N; Vicente V; Corral J PLoS One; 2016; 11(3):e0152159. PubMed ID: 27003919 [TBL] [Abstract][Full Text] [Related]
42. The antithrombin III gene polymorphism in Japan: examination for haplotypes relevant to disordered antithrombin III biosynthesis. Oguma Y; Sakuragawa N; Hiraga K Thromb Res; 1992 Mar; 65(4-5):519-31. PubMed ID: 1352068 [TBL] [Abstract][Full Text] [Related]
43. Arterial and venous thrombosis and prothrombotic fibrin clot phenotype in a Polish family with type 1 antithrombin deficiency (antithrombin Krakow). Celinska-Lowenhoff M; Iwaniec T; Alhenc-Gelas M; Musial J; Undas A Thromb Haemost; 2011 Aug; 106(2):379-81. PubMed ID: 21655678 [No Abstract] [Full Text] [Related]
44. New genetic variant in the SERPINC1 gene: hereditary Antithrombin deficiency case report, familial thrombosis and considerations on genetic counseling. Polyak ME; Zaklyazminskaya EV BMC Med Genet; 2020 Apr; 21(1):73. PubMed ID: 32252658 [TBL] [Abstract][Full Text] [Related]
45. Identification of the antithrombin III Kyoto mutation by restriction fragment length polymorphism analysis. Masuda H; Tsuji H; Nakagawa K; Nakahara Y; Kitamura H; Ogasahara Y; Nakagawa M Int J Hematol; 1995 Jun; 61(4):197-204. PubMed ID: 8547608 [TBL] [Abstract][Full Text] [Related]
46. Antithrombin-Gly 424 Arg: a novel point mutation responsible for type 1 antithrombin deficiency and neonatal thrombosis. Jochmans K; Lissens W; Vervoort R; Peeters S; De Waele M; Liebaers I Blood; 1994 Jan; 83(1):146-51. PubMed ID: 8274732 [TBL] [Abstract][Full Text] [Related]
47. Use of synthetic oligonucleotides in the characterization of antithrombin III Northwick Park (393 CGT----TGT) and antithrombin III Glasgow (393 CGT----CAT). Thein SL; Lane DA Blood; 1988 Nov; 72(5):1817-21. PubMed ID: 3179448 [TBL] [Abstract][Full Text] [Related]
48. Effect of danazol on the biochemical abnormality of inherited antithrombin III deficiency. Fairfax AJ; Ibbotson RM Thorax; 1985 Sep; 40(9):646-50. PubMed ID: 4060104 [TBL] [Abstract][Full Text] [Related]
49. Genetic analysis should be included in clinical practice when screening for antithrombin deficiency. Zeng W; Tang L; Jian XR; Li YQ; Guo T; Wang QY; Liu H; Wu YY; Cheng ZP; Hu B; Lu X; Yu JM; Deng J; Wang HF; Sun CY; Yang Y; Hu Y Thromb Haemost; 2015 Feb; 113(2):262-71. PubMed ID: 25298121 [TBL] [Abstract][Full Text] [Related]
50. Congenital anti-thrombin III deficiency with mesenteric venous thrombosis--functional and immunological estimations. Dale BM; Naujalis J; Barber S Pathology; 1984 Oct; 16(4):424-30. PubMed ID: 6522108 [TBL] [Abstract][Full Text] [Related]
51. An overview of the mechanism of action of antithrombin and its inherited deficiency states. Blajchman MA Blood Coagul Fibrinolysis; 1994 Jan; 5 Suppl 1():S5-11; discussion S59-64. PubMed ID: 8186357 [TBL] [Abstract][Full Text] [Related]
52. A novel mutation of antithrombin deficiency in six family siblings and the clinical combat. Nadir Y; Hoffman R; Corral J; Barak Y; Hasin T; Keren-Politansky A; Brenner B Thromb Haemost; 2015 Oct; 114(4):859-61. PubMed ID: 26177694 [No Abstract] [Full Text] [Related]
53. Hereditary antithrombin III deficiency in an English family. Scully MF; De Haas H; Chan P; Kakkar VV Br J Haematol; 1981 Feb; 47(2):235-40. PubMed ID: 7470393 [TBL] [Abstract][Full Text] [Related]
54. Familial deficiency of antithrombin III: evidence for heterogeneity existing within the family. d'Souza S; Ekert H Aust N Z J Med; 1984 Dec; 14(6):835-40. PubMed ID: 6598052 [TBL] [Abstract][Full Text] [Related]
55. Molecular genetics of inherited antithrombin III deficiencies. Prochownik EV Am J Med; 1989 Sep; 87(3B):15S-18S. PubMed ID: 2572168 [TBL] [Abstract][Full Text] [Related]
56. Antithrombin Debrecen (p.Leu205Pro) - Clinical and molecular characterization of a novel mutation associated with severe thrombotic tendency. Selmeczi A; Gindele R; Ilonczai P; Fekete A; Komáromi I; Schlammadinger Á; Rázsó K; Kovács KB; Bárdos H; Ádány R; Muszbek L; Bereczky Z; Boda Z; Oláh Z Thromb Res; 2017 Oct; 158():1-7. PubMed ID: 28783511 [TBL] [Abstract][Full Text] [Related]
57. Conformational Asn187Asp/Lys antithrombin variants and thrombosis. Clinical and biological features in 13 new heterozygotes. Picard V; Bauters A; Khairy M; Ochat N; Jude B; Aiach M; Alhenc-Gelas M Thromb Haemost; 2005 Jan; 93(1):57-62. PubMed ID: 15630491 [TBL] [Abstract][Full Text] [Related]
58. Antithrombin Dublin (p.Val30Glu): a relatively common variant with moderate thrombosis risk of causing transient antithrombin deficiency. Navarro-Fernández J; de la Morena-Barrio ME; Padilla J; Miñano A; Bohdan N; Águila S; Martínez-Martínez I; Sevivas TS; de Cos C; Fernández-Mosteirín N; Llamas P; Asenjo S; Medina P; Souto JC; Overvad K; Kristensen SR; Corral J; Vicente V Thromb Haemost; 2016 Jul; 116(1):146-54. PubMed ID: 27098529 [TBL] [Abstract][Full Text] [Related]
60. Familial thrombosis associated with antithrombin III deficiency in a young adult male. A case report. Hofman KJ; Goldman AP; Lurie M; Hockly J; Bradlow BA S Afr Med J; 1980 Sep; 58(13):531-3. PubMed ID: 7423287 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]